A study of Intervertebral disc prolapse management effect of homoeopathic medicines

THE EFFECT OF HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF INTERVERTEBRAL DISC PROLAPSE- A QUASI EXPERIMENTAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/073082

Enrollment

Registered

2024-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Constitutional Homoeopathic medicines: After assessing the totality of symptoms of each patient, consider the most suitable homoeopathic medicinal intervention with the help of proper r

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with signs and symptoms of Intervertebral Disc Prolapse with Positive MRI Spine changes. 2. Age group 25 to 65 years. 3. Subjects belonging to both sexes.

Exclusion criteria

Exclusion criteria: 1. Patients with complicated systemic illness. 2. Patients with Spinal injuries. 3. Patients undergone any Spinal surgeries.

Design outcomes

Primary

Measure	Time frame
Title: Reduction of Oswestry Disability Index Description: Oswestry Disability Index baseline score – Oswestry Disability Index final score. Interval: 6 monthsTimepoint: After medicinal prescription according to homoeopathic Principle, assess Reduction of Oswestry Disability Index after 6months from the baseline score	—

Secondary

Measure	Time frame
Title: Reduction of VAS Score Description: VAS Score baseline – VAS Score final. Interval: 6 monthsTimepoint: After medicinal prescription according to homoeopathic Principle, assess Reduction of VAS Score after 6months from the baseline score	—

Countries

India

Contacts

Public ContactDr Lizmy Jose

Government Homoeopathic Medical College

lizmyajith@gmail.com9447551747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026